Xenon Pharmaceuticals
Chad Fugere is an experienced finance professional currently serving as Vice President of Investor Relations at Xenon Pharmaceuticals Inc., a role commenced in February 2024. Previously, Chad held the position of Senior Director of Investor Relations at Seagen from August 2021 to February 2024. Chad's career also includes significant roles such as Senior Investment Analyst at American Century Investments, Principal and Senior Research Analyst at First Light Asset Management, and Senior Research Analyst at both Wells Capital Management and Wachovia Capital Markets, LLC. Educational credentials include an MBA in Finance from the UMN Carlson School of Management and a BA in Economics from the University of South Florida.
This person is not in any teams
This person is not in any offices